Royal Bank of Canada’s Monogram Orthopaedics MGRM Stock Holding History

Royal Bank of Canada’s Portfolio MGRM Stock Details MGRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,615	Closed	-$9K	–	7436
2025 Q3	$9K	Buy	+1,615	New	+$8.63K	﹤0.01%	6529
2024 Q3	–	Sell	-49	Closed	–	–	7199
2024 Q2	$0	Buy	49 +28	+133%	+$61	﹤0.01%	7345
2024 Q1	$0	Buy	21 +4	+24%	+$12	﹤0.01%	7358
2023 Q4	$0	Buy	+17	New	+$51	﹤0.01%	7400

Royal Bank of Canada's MGRM Position: Q4 2025 in Review

Royal Bank of Canada sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 1,615 shares — an estimated $9K sold.

Royal Bank of Canada first reported a position in MGRM in Q4 2023 and held it in 4 quarters. The position peaked at $9K in Q3 2025. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

Royal Bank of Canada reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
Royal Bank of Canada sold 1,615 Monogram Orthopaedics shares in Q4 2025, an estimated $9K.
Royal Bank of Canada first reported a position in Monogram Orthopaedics in Q4 2023 and held it in 4 quarters.
Royal Bank of Canada's Monogram Orthopaedics position peaked at $9K in Q3 2025.
0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.